Replies to post #1683 on Insmed Inc (INSM)

[jellybean]

thanks for the reply CF.

The Noonan's syndrome trials have not yet started, so there is no way the company could be waiting for EMEA approval.

However, it may be that they have begun the approval for IGFD and GH insensitivity due to antibodies.